Conshohocken, PA (PRWEB) February 04, 2014
The pharmaceutical industry is at a crossroads. The era of writing one prescription after another is over. Patients, advocacy groups, payers, government, and others are asking for better outcomes. Enter digital medicine. To help pharmaceutical companies better understand how digital medicine will redefine the pharmaceutical business model, Pharmica will host its “Pharma 3.0 – The Digital Medicine Era” conference in Conshohocken, PA on April 30th & May 1st, 2014.
“Steven R. Steinhubl is the Director of Digital Medicine at Scripps Translational Science Institute and he is leading a number of trials focused on developing the evidence base necessary to establish the role of mobile health technologies in the transformation of the healthcare system,” said Matt Hendricks, Partner with Pharmica Consulting.
“We are excited to hear Steve discuss the advancements in mobile technology and connectivity over the last several decades, and how these have provided the foundation needed to dramatically change the way healthcare is currently practiced. He will present evidence supporting digital medicine’s potential to impact the delivery of care, improve outcomes, and lower costs.”
Those interested in learning more about Pharmica Consulting and upcoming forums or service offerings can visit http://www.pharmicaconsulting.com/services. To request additional information, please contact Greg Cohee at 215-579-1650 or Matt Kiernan at 610-945-4364.
About Pharmica Consulting:
Pharmica Consulting, one of the Life sciences Industry leading consulting firms, provides a variety of offerings designed to help pharmaceutical and biotech clients achieve true operational excellence. Consultants at Pharmica invest the time needed to truly understand a client’s specific challenges and tailor solutions to help them create a more profitable business environment. Pharmica Consulting knows how to build effective strategies - and deliver against those strategies as promised.